Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 56

1.

Recurring Nephrotic Syndrome After Lithium Medication: A Case Report.

Reinhard MA, Wilkening A, Müller-Oerlinghausen B, Grohmann R.

J Clin Psychopharmacol. 2019 Jul 19. doi: 10.1097/JCP.0000000000001078. [Epub ahead of print] No abstract available.

PMID:
31335443
2.

Clinical use of lithium salts: guide for users and prescribers.

Tondo L, Alda M, Bauer M, Bergink V, Grof P, Hajek T, Lewitka U, Licht RW, Manchia M, Müller-Oerlinghausen B, Nielsen RE, Selo M, Simhandl C, Baldessarini RJ; International Group for Studies of Lithium (IGSLi).

Int J Bipolar Disord. 2019 Jul 22;7(1):16. doi: 10.1186/s40345-019-0151-2. Review.

3.

Alec J. Coppen-A pioneering psychiatrist who discovered the pivotal role of serotonin in the pathogenesis of depression as well as the antisuicidal effect of lithium.

Müller-Oerlinghausen B, Abou-Saleh MT.

Int J Bipolar Disord. 2019 Jul 2;7(1):15. doi: 10.1186/s40345-019-0150-3. No abstract available.

4.

Are the antidepressive effects of massage therapy mediated by restoration of impaired interoceptive functioning? A novel hypothetical mechanism.

Eggart M, Queri S, Müller-Oerlinghausen B.

Med Hypotheses. 2019 Jul;128:28-32. doi: 10.1016/j.mehy.2019.05.004. Epub 2019 May 11.

PMID:
31203905
5.

Major Depressive Disorder Is Associated with Impaired Interoceptive Accuracy: A Systematic Review.

Eggart M, Lange A, Binser MJ, Queri S, Müller-Oerlinghausen B.

Brain Sci. 2019 Jun 6;9(6). pii: E131. doi: 10.3390/brainsci9060131. Review.

6.

MOGENS SCHOU: 100th anniversary of his birth.

Grof P, Müller-Oerlinghausen B.

Int J Bipolar Disord. 2018 Nov 28;6(1):27. doi: 10.1186/s40345-018-0138-4. No abstract available.

7.

Suicidal Ideation and Suicidal Behavior as Rare Adverse Events of Antidepressant Medication: Current Report from the AMSP Multicenter Drug Safety Surveillance Project.

Stübner S, Grohmann R, Greil W, Zhang X, Müller-Oerlinghausen B, Bleich S, Rüther E, Möller HJ, Engel R, Falkai P, Toto S, Kasper S, Neyazi A.

Int J Neuropsychopharmacol. 2018 Sep 1;21(9):814-821. doi: 10.1093/ijnp/pyy048.

8.

Lithium Clinics in Berlin and Dresden: a 50-Year Experience.

Felber W, Bauer M, Lewitzka U, Müller-Oerlinghausen B.

Pharmacopsychiatry. 2018 Sep;51(5):166-171. doi: 10.1055/a-0633-3450. Epub 2018 Jun 14. Review.

PMID:
29902821
9.

Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters.

Tondo L, Abramowicz M, Alda M, Bauer M, Bocchetta A, Bolzani L, Calkin CV, Chillotti C, Hidalgo-Mazzei D, Manchia M, Müller-Oerlinghausen B, Murru A, Perugi G, Pinna M, Quaranta G, Reginaldi D, Reif A, Ritter P Jr, Rybakowski JK, Saiger D, Sani G, Selle V, Stamm T, Vázquez GH, Veeh J, Vieta E, Baldessarini RJ.

Int J Bipolar Disord. 2017 Dec;5(1):27. doi: 10.1186/s40345-017-0096-2. Epub 2017 Aug 1.

10.

Lithium in the episode and suicide prophylaxis and in augmenting strategies in patients with unipolar depression.

Abou-Saleh MT, Müller-Oerlinghausen B, Coppen AJ.

Int J Bipolar Disord. 2017 Dec;5(1):11. doi: 10.1186/s40345-017-0080-x. Epub 2017 May 8. Review.

11.

Stability of lithium treatment in bipolar disorder - long-term follow-up of 346 patients.

Berghöfer A, Alda M, Adli M, Baethge C, Bauer M, Bschor T, Grof P, Müller-Oerlinghausen B, Rybakowski JK, Suwalska A, Pfennig A.

Int J Bipolar Disord. 2013 Jul 31;1:11. doi: 10.1186/2194-7511-1-11. eCollection 2013.

12.

Commentary on a recent review of lithium toxicity: what are its implications for clinical practice?

Müller-Oerlinghausen B, Bauer M, Grof P.

BMC Med. 2012 Nov 2;10:132. doi: 10.1186/1741-7015-10-132.

13.

[Psychotherapy should be verifiable too].

Müller-Oerlinghausen B.

MMW Fortschr Med. 2011 Sep 29;153(39):30. German. No abstract available.

PMID:
21991832
14.

Correspondence (letter to the editor): Cooperation of all participating groups.

Müller-Oerlinghausen B, Aly AF.

Dtsch Arztebl Int. 2010 Aug;107(31-32):558-9; author reply 559-60. doi: 10.3238/arztebl.2010.0558b. Epub 2010 Aug 9. No abstract available.

15.

Suicidality as rare adverse event of antidepressant medication: report from the AMSP multicenter drug safety surveillance project.

Stübner S, Grohmann R, von Stralendorff I, Rüther E, Möller HJ, Müller-Oerlinghausen B, Engel RR, Horvath A, Greil W.

J Clin Psychiatry. 2010 Oct;71(10):1293-307. doi: 10.4088/JCP.09m05912blu. Epub 2010 Aug 10.

PMID:
20816032
16.

Influence of atypical features on the quality of prophylactic effectiveness of long-term lithium treatment in bipolar disorders.

Pfennig A, Schlattmann P, Alda M, Grof P, Glenn T, Müller-Oerlinghausen B, Suwalska A, Rybakowski J, Willich SN, Bauer M, Berghöfer A.

Bipolar Disord. 2010 Jun;12(4):390-6. doi: 10.1111/j.1399-5618.2010.00826.x.

PMID:
20636636
17.

Lithium reduces pathological aggression and suicidality: a mini-review.

Müller-Oerlinghausen B, Lewitzka U.

Neuropsychobiology. 2010;62(1):43-9. doi: 10.1159/000314309. Epub 2010 May 7. Review.

PMID:
20453534
18.

Some additional points.

Müller-Oerlinghausen B.

Dtsch Arztebl Int. 2009 May;106(18):319; author reply 321-2. doi: 10.3238/arztebl.2009.0319b. Epub 2009 May 1. No abstract available.

19.

A critical appraisal of lithium's efficacy and effectiveness: the last 60 years.

Grof P, Müller-Oerlinghausen B.

Bipolar Disord. 2009 Jun;11 Suppl 2:10-9. doi: 10.1111/j.1399-5618.2009.00707.x. Review.

PMID:
19538682
20.

[Improving drug safety in Germany: an alliance between the government and the medical profession].

Müller-Oerlinghausen B, Ludwig WD.

Z Evid Fortbild Qual Gesundhwes. 2008;102(9):582-6; discussion 593, 606-8. German.

PMID:
19213455

Supplemental Content

Loading ...
Support Center